Literature DB >> 23376074

Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression.

Benjamin Koopmansch1, Geert Berx, Jean-Michel Foidart, Christine Gilles, Rosita Winkler.   

Abstract

E-cadherin expression is repressed by ZEB2/SIP1 while it is induced by KLF4. Independent data from the literature indicate that these two transcription factors could bind close to each other in the proximal region of the E-cadherin gene promoter. We have here explored a potential competition between ZEB2 and KLF4 for the binding to the E-cadherin promoter. We show an inverse correlation between ZEB2 expression levels and KLF4 recruitment on the E-cadherin promoter in three breast cancer cell lines and in A431/HA.ZEB2 cells in which ZEB2 expression is induced by doxycycline (DOX). We identified a region of the E-cadherin promoter bound by KLF4 which is necessary for the activation of the E-cadherin promoter activity after KLF4 overexpression. This region is localized between positions -28 and -10 and thus overlaps with one of the ZEB2 binding sites. Deleting the bipartite ZEB2 binding site results in increased KLF4 induced E-cadherin promoter activity. Taken together, our results suggest that E-cadherin expression in cancer cells is controlled by a balance between ZEB2 and KLF4 expression levels.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376074     DOI: 10.1016/j.bbrc.2013.01.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.

Authors:  Fanyang Kong; Tao Sun; Xiangyu Kong; Dacheng Xie; Zhaoshen Li; Keping Xie
Journal:  Clin Cancer Res       Date:  2018-01-24       Impact factor: 12.531

2.  Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma.

Authors:  Changmei Liu; Fangmei Yang
Journal:  Tumour Biol       Date:  2015-04-19

Review 3.  Regulation of EMT by KLF4 in gastrointestinal cancer.

Authors:  Jiujie Cui; Min Shi; Ming Quan; Keping Xie
Journal:  Curr Cancer Drug Targets       Date:  2013-11       Impact factor: 3.428

4.  ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.

Authors:  Ming-Zhe Li; Jing-Jing Wang; Shi-Bin Yang; Wen-Feng Li; Long-Bin Xiao; Yu-Long He; Xin-Ming Song
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

Review 5.  The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer.

Authors:  Ioannis A Voutsadakis
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-09-07

Review 6.  Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma.

Authors:  Guangbing Li; Haohai Zhang; Xueshuai Wan; Xiaobo Yang; Chengpei Zhu; Anqiang Wang; Lian He; Ruoyu Miao; Shuguang Chen; Haitao Zhao
Journal:  Biomed Res Int       Date:  2014-03-16       Impact factor: 3.411

7.  NAC1 Regulates Somatic Cell Reprogramming by Controlling Zeb1 and E-cadherin Expression.

Authors:  Francesco Faiola; Nuoya Yin; Miguel Fidalgo; Xin Huang; Arven Saunders; Junjun Ding; Diana Guallar; Baoyen Dang; Jianlong Wang
Journal:  Stem Cell Reports       Date:  2017-08-03       Impact factor: 7.765

8.  MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.

Authors:  Jiacong You; Yang Li; Nianzhen Fang; Bin Liu; Lingling Zu; Rui Chang; Xuebing Li; Qinghua Zhou
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

9.  Krüppel-Like Factor 4 Overexpression Initiates a Mesenchymal-to-Epithelial Transition and Redifferentiation of Human Pancreatic Cells following Expansion in Long Term Adherent Culture.

Authors:  Kenneth R Muir; Maria João Lima; Hilary M Docherty; Neil W A McGowan; Shareen Forbes; Yves Heremans; Stuart J Forbes; Harry Heimberg; John Casey; Kevin Docherty
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

10.  Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma.

Authors:  Xiqing Li; Zhunlan Zhao; Xiaoling Zhang; Sheng Yang; Xia Lin; Xinglong Yang; Xiaolin Lin; Junwen Shi; Shengchun Wang; Wentao Zhao; Jing Li; Fei Gao; Mingyue Liu; Ning Ma; Weiren Luo; Kaitai Yao; Yan Sun; Shengjun Xiao; Dong Xiao; Junshuang Jia
Journal:  Oncotarget       Date:  2017-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.